R. Hammer, S. Maika, J. Richardson, J. Tang, and J. Taurog, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human ??2m: An animal model of HLA-B27-associated human disorders, Cell, vol.63, issue.5, pp.1099-1112, 1990.
DOI : 10.1016/0092-8674(90)90512-D

C. Pachebo-tena, X. Zhang, M. Stone, R. Burgos-vargas, and R. Inman, Innate immunity in host-microbial interactions: Beyond B27 in the spondyloarthropathies, Current Opinion in Rheumatology, vol.14, issue.4, pp.373-382, 2002.
DOI : 10.1097/00002281-200207000-00007

D. Baeten, P. Demetter, C. Cuvelier, . Van-den, . Bosch et al., Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, Annals of the Rheumatic Diseases, vol.59, issue.12, pp.945-953, 2000.
DOI : 10.1136/ard.59.12.945

L. Laloux, M. Voisin, J. Allain, N. Martin, L. Kerboull et al., Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis, Annals of the Rheumatic Diseases, vol.60, issue.4, pp.316-321, 2001.
DOI : 10.1136/ard.60.4.316

E. Toussirot and D. Wendling, Immunog??n??tique de??la??spondylarthrite ankylosante, La Revue de M??decine Interne, vol.27, issue.10, pp.762-771, 2006.
DOI : 10.1016/j.revmed.2006.05.005

D. Lenschow, T. Walunas, and J. Bluestone, CD28/B7 SYSTEM OF T CELL COSTIMULATION, Annual Review of Immunology, vol.14, issue.1, pp.233-258, 1996.
DOI : 10.1146/annurev.immunol.14.1.233

W. Teft, M. Kirchhof, and J. Madrenas, A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION, Annual Review of Immunology, vol.24, issue.1, pp.65-97, 2006.
DOI : 10.1146/annurev.immunol.24.021605.090535

B. Carreno, F. Bennett, T. Chau, V. Ling, D. Luxenberg et al., CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression, The Journal of Immunology, vol.165, issue.3, pp.1352-1356, 2000.
DOI : 10.4049/jimmunol.165.3.1352

K. Wing, Y. Onishi, P. Prieto-martin, T. Yamaguchi, M. Miyara et al., CTLA-4 Control over Foxp3+ Regulatory T Cell Function, Science, vol.322, issue.5899, pp.271-275, 2008.
DOI : 10.1126/science.1160062

M. Oaks, K. Hallett, R. Penwell, E. Stauber, S. Warren et al., A Native Soluble Form of CTLA-4, Cellular Immunology, vol.201, issue.2, pp.144-153, 2000.
DOI : 10.1006/cimm.2000.1649

E. Pawlak, I. Kochanowska, I. Frydecka, M. Kielbinski, S. Potoczek et al., The soluble CTLA-4 receptor: a new marker in autoimmunes diseases, Arch Immunol Ther Exp, vol.53, pp.336-341, 2005.

M. Oaks and K. Hallett, Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease, The Journal of Immunology, vol.164, issue.10, pp.5015-5018, 2000.
DOI : 10.4049/jimmunol.164.10.5015

X. Wang, M. Kakuolidou, R. Giscombe, Q. Qiu, D. Huang et al., Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence, Journal of Neuroimmunology, vol.130, issue.1-2, pp.224-232, 2002.
DOI : 10.1016/S0165-5728(02)00228-X

M. Liu, C. Wang, P. Chen, and L. Fung, Increased Expression of Soluble Cytotoxic T-Lymphocyte-Associated Antigen-4 Molecule in Patients with Systemic Lupus Erythematosus, Scandinavian Journal of Immunology, vol.164, issue.6, pp.568-572, 2003.
DOI : 10.1006/bbrc.1996.1256

C. Wong, L. Lit, L. Tam, E. Li, and C. Lam, Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus, Rheumatology, vol.44, issue.8, pp.989-994, 2005.
DOI : 10.1093/rheumatology/keh663

S. Sato, M. Fujimoto, M. Hasegawa, K. Komura, K. Yanaba et al., Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis, Rheumatology, vol.43, issue.10, pp.1261-1266, 2004.
DOI : 10.1093/rheumatology/keh303

H. Ueda, J. Howson, L. Esposito, J. Heward, H. Snook et al., Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease, Nature, vol.423, issue.6939, pp.506-511, 2003.
DOI : 10.1038/nature01621

M. Dougados, S. Linden, . Van-der, R. Juhlin, B. Huitfeldt et al., The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy, Arthritis & Rheumatism, vol.57, issue.10, pp.1218-1227, 1991.
DOI : 10.1002/art.1780341003

P. Garrett, T. Jenkinsson, L. Kennedy, H. Whitelock, P. Gaisford et al., A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, vol.21, pp.2286-2291, 1994.

A. Calin, S. Garrett, H. Whitelock, L. Kennedy, O. Hea et al., A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index (BASFI), J Rheumatol, vol.21, pp.2281-2285, 1994.

F. Arnett, S. Edworthy, D. Bloch, D. Mcshane, J. Fries et al., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-324, 1988.
DOI : 10.1002/art.1780310302

E. Tan, A. Cohen, J. Fries, A. Masi, D. Mcshane et al., The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1277, 1982.
DOI : 10.1002/art.1780251101

K. Reimann, O. Gorman, M. Spritzler, J. Wilkening, C. Sabath et al., Multisite comparison of CD4 and CD8 Tlymphocyte counting by single-versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group, Clin Diagn Lab Immunol, vol.7, pp.344-351, 2000.

D. Tran, H. Ramsey, and E. Shevach, Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-?? dependent but does not confer a regulatory phenotype, Blood, vol.110, issue.8, pp.2983-2990, 2007.
DOI : 10.1182/blood-2007-06-094656

M. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001.
DOI : 10.1093/nar/29.9.e45

S. Agarwal, G. Marshall, and . Jr, Role of CD28/B7 Costimulation in the Dexamethasone-Induced Suppression of IFN-??, Journal of Interferon & Cytokine Research, vol.20, issue.11, pp.927-934, 2000.
DOI : 10.1089/10799900050198363

X. Qin, H. Shi, S. Qin, L. Kang, C. Huang et al., Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics, Allergy, vol.133, issue.6, pp.774-779, 2005.
DOI : 10.1016/j.jaci.2004.03.050

C. Hacquard-bouder, G. Flagarone, A. Bosquet, F. Smaoui, D. Monnet et al., Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy, Arthritis & Rheumatism, vol.30, issue.5, pp.1624-1635, 2004.
DOI : 10.1002/art.20211

D. Cao, R. Van-vollenhoven, L. Klareskog, C. Trollmo, and V. Malmstrom, CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease, Arthritis Research & Therapy, vol.6, issue.4, pp.335-346, 2004.
DOI : 10.1186/ar1192

C. Manzotti, H. Tipping, L. Perry, K. Mead, P. Blair et al., Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells, European Journal of Immunology, vol.32, issue.10, pp.2888-2896, 2002.
DOI : 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F

M. Liu, H. Kohsaka, H. Sakurai, M. Azuma, K. Okumura et al., The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium, Arthritis & Rheumatism, vol.91, issue.1, pp.110-114, 1996.
DOI : 10.1002/art.1780390115

M. Ehrenstein, J. Evans, A. Singh, S. Moore, G. Warnes et al., Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF?? Therapy, The Journal of Experimental Medicine, vol.155, issue.3, pp.277-285, 2004.
DOI : 10.1186/ar414

F. Flores-borja, E. Jury, C. Mauri, and M. Ehrenstein, Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis, Proceedings of the National Academy of Sciences, vol.105, issue.49, pp.19396-19401, 2008.
DOI : 10.1073/pnas.0806855105

I. Olivieri, D. Angelo, S. Mennillo, G. Pistone, G. Scarano et al., Abatacept in spondyloarthritis refractory to tumour necrosis factor ?? inhibition, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.151-152, 2009.
DOI : 10.1136/ard.2008.097030